BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Long Term Debt

Latest long-term debt for MLTX: $100M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$100.29M
↑ 35.13% YoYΔ $26.07M vs prior year quarter

Peer trimmed avg / median

Loading

MoonLake Immunotherapeutics Long Term Debt History

Loading

MoonLake Immunotherapeutics vs. peers: Long Term Debt Comparison

Loading

MoonLake Immunotherapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MoonLake Immunotherapeutics (MLTX) FAQ

As of the most recent data (June 2026), MLTX shows a long-term debt of $100M. That compares with $74M in the prior-year period — up 35.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLTX's long-term debt is now $100M (was $74M) — a 35.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MoonLake Immunotherapeutics is outperforming or lagging.

Tracking MLTX's long-term debt over time shows whether MoonLake Immunotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $100M That compares with $74M in the prior-year period — up 35.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has MoonLake Immunotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $100M) with ownership activity and broader fundamentals.